Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome.

Journal: Metabolomics : Official journal of the Metabolomic Society
Published Date:

Abstract

INTRODUCTION: There are significant challenges remain in accurately categorizing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients.

Authors

  • Hien Thi Thu Nguyen
    Department of Molecular Diagnostics, Aalborg University Hospital, Reberbansgade 15, 9000, Aalborg, Denmark. hien@rn.dk.
  • Malene Pontoppidan Stoico
    Department of Molecular Diagnostics, Aalborg University Hospital, Reberbansgade 15, 9000, Aalborg, Denmark.
  • Vang Quy Le
    NOVODAN ApS, Aalborg, Denmark.
  • Jakob Holm Dalsgaard Thomsen
    Department of Molecular Diagnostics, Aalborg University Hospital, Reberbansgade 15, 9000, Aalborg, Denmark.
  • Kasper Bygum Krarup
    Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark.
  • Karoline Assifuah Kristjansen
    Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Inge Søkilde Pedersen
    Department of Molecular Diagnostics, Aalborg University Hospital, Reberbansgade 15, 9000, Aalborg, Denmark.
  • Henrik Bygum Krarup
    Department of Molecular Diagnostics, Aalborg University Hospital, Reberbansgade 15, 9000, Aalborg, Denmark.